Cullinan Therapeutics Inc (CGEM)
24.02
+0.21
(+0.88%)
USD |
NASDAQ |
May 20, 16:00
24.02
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics Total Assets (Quarterly): 449.43M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 449.43M |
| December 31, 2023 | 484.18M |
| September 30, 2023 | 494.71M |
| June 30, 2023 | 521.98M |
| March 31, 2023 | 514.99M |
| December 31, 2022 | 561.12M |
| September 30, 2022 | 617.24M |
| June 30, 2022 | 667.25M |
| Date | Value |
|---|---|
| March 31, 2022 | 437.46M |
| December 31, 2021 | 437.18M |
| September 30, 2021 | 453.40M |
| June 30, 2021 | 464.35M |
| March 31, 2021 | 479.67M |
| December 31, 2020 | 214.71M |
| September 30, 2020 | 222.02M |
| December 31, 2019 | 100.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
100.46M
Minimum
Dec 2019
667.25M
Maximum
Jun 2022
445.01M
Average
472.01M
Median
Total Assets (Quarterly) Benchmarks
| Fate Therapeutics Inc | 569.89M |
| Viking Therapeutics Inc | 967.52M |
| Allogene Therapeutics Inc | 586.35M |
| Applied Therapeutics Inc | 151.23M |
| Nkarta Inc | 576.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.76M |
| Shareholders Equity (Quarterly) | 425.66M |